Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?

The pandemics of coronavirus disease 2019 (COVID-19) and non-alcoholic fatty liver disease (NAFLD) coexist. Elevated liver function tests are frequent in COVID-19 and may influence liver damage in NAFLD, while preexisting liver damage from NAFLD may influence the course of COVID-19. However, the pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietrich, Christoph G, Geier, Andreas, Merle, Uta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2023
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846932/
https://www.ncbi.nlm.nih.gov/pubmed/36687116
http://dx.doi.org/10.3748/wjg.v29.i2.367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846932/
https://www.ncbi.nlm.nih.gov/pubmed/36687116
http://dx.doi.org/10.3748/wjg.v29.i2.367

Ejemplares similares